Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 19 recruiting now official registry

Seizures clinical trials

Every US clinical trial registered for Seizures — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

40 US clinical trials · 19 currently recruiting

The research picture

Seizures has 40 registered US clinical trials, 19 of them open to new participants right now — about 48% of the total.

19
recruiting participants now
48%
of trials open to enrollment
6
in Phase 3–4 (later-stage)
4
top sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING 20,000 participants

De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information

University of New Mexi

NCT05140265

RECRUITING Phase 3 6,700 participants

Pediatric Dose Optimization for Seizures in Emergency Medical Services

Stanford University

NCT05121324

RECRUITING 2,500 participants

Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children

Children's Hospital of Philadelphia

NCT03419260

RECRUITING 1,000 participants

Longitudinal Study of Neurogenetic Disorders

Columbia University

NCT03492060

RECRUITING 1,000 participants

Investigating Epilepsy: Screening and Evaluation

National Institute of Neurological Disorders and Stroke (NINDS)

NCT03478852

RECRUITING 600 participants

Genetic Markers of Cardiovascular Disease in Epilepsy

Mayo Clinic

NCT02824822

RECRUITING NA 400 participants

Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

University of Florida

NCT02216500

RECRUITING Phase 3 252 participants

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

SK Life Science

NCT05219617

RECRUITING NA 190 participants

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Neuroelectrics Corporation

NCT04770337

RECRUITING Phase 2 150 participants

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Ayal A. Aizer, MD

NCT07130786

RECRUITING NA 65 participants

Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.

Epitel

NCT06027749

RECRUITING NA 62 participants

Oxygen Toxicity: Mechanisms in Humans

Duke University

NCT05761756

RECRUITING Early Phase 1 60 participants

Pharmacological Modulation of Brain Oscillations in Memory Processing

University of Texas Southwestern Medical Center

NCT05594017

RECRUITING Phase 2 52 participants

PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest

University of California, San Francis

NCT06401707

RECRUITING NA 40 participants

Ear-Seizure Detection (EarSD) Study

Felicia Chu

NCT06598189

RECRUITING NA 30 participants

Modulating Movement Intention Via Cortical Stimulation

NYU Langone Health

NCT03233399

RECRUITING Phase 2 30 participants

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

University of California, San Francis

NCT05851391

RECRUITING NA 25 participants

Glioblastoma Remote Monitoring and Care - Research Protocol

Case Comprehensive Cancer Center

NCT06129760

RECRUITING NA 10 participants

Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients

Yale University

NCT05784805

ACTIVE NOT RECRUITING 39 participants

Neural Circulatory Control and SUDEP Risk.

Mayo Clinic

NCT02813980

ACTIVE NOT RECRUITING Phase 2 24 participants

RNS System LGS Feasibility Study

NeuroPace

NCT05339126

ACTIVE NOT RECRUITING Phase 1 5 participants

BHV-7000 Responsive Neurostimulation System (RNS) Study

Yale University

NCT07125261

COMPLETED Phase 3 720 participants

Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly.

US Department of Veterans Affairs

NCT00007670

COMPLETED Phase 3 453 participants

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

Children's Hospital Medical Center, Cincinnati

NCT00088452

COMPLETED Phase 2 358 participants

Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures

University of Utah

NCT00326612

COMPLETED Phase 3 306 participants

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

GlaxoSmithKline

NCT00232596

COMPLETED 300 participants

Revisiting Survey Investigating Why Patients Are Not Receiving Home Anti-convulsant Medication Prior to Surgery/or Procedure Involving General Anesthesia

Vidya Raman

NCT01897974

COMPLETED Phase 2 274 participants

Hypovitaminosis D in Neurocritical Patients

University of Utah

NCT02881957

COMPLETED Phase 3 238 participants

Clobazam in Patients With Lennox-Gastaut Syndrome

Lundbeck

NCT00518713

COMPLETED 185 participants

Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study

Icahn School of Medicine at Mount Sinai

NCT00041951

COMPLETED 80 participants

Metabolic Abnormalities in Children With Epilepsy

National Institute of Neurological Disorders and Stroke (NINDS)

NCT00001325

COMPLETED Phase 1 61 participants

Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders

INSYS Therapeutics

NCT02324673

COMPLETED Phase 1 59 participants

Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions

Roxane Laboratories

NCT01703468

COMPLETED 40 participants

Evaluation of StatNet Device for Electroencephalogram (EEG) Recordings

Beth Israel Deaconess Medical Center

NCT03103425

COMPLETED Phase 1 39 participants

Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector

U.S. Army Office of the Surgeon General

NCT00534378

COMPLETED 34 participants

Database Of Clinical Data For Individuals With Variants In The IRF2BPL Gene

Children's Hospital Medical Center, Cincinnati

NCT03892798

COMPLETED 32 participants

Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy

National Institute of Neurological Disorders and Stroke (NINDS)

NCT00001666

COMPLETED Phase 2 19 participants

Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency

National Institute of Neurological Disorders and Stroke (NINDS)

NCT02019667

COMPLETED Phase 1 12 participants

Effect of Perampanel on Peritumoral Hyperexcitability in HGG

Dana-Farber Cancer Institute

NCT04497142

COMPLETED 6 participants

Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis

National Institute of Allergy and Infectious Diseases (NIAID)

NCT00001912

Phase Distribution

PhaseTrial count
Phase 1 6
Phase 2 7
Phase 3 6

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Seizures Trial Landscape

ClinicalTrials.gov lists 40 US studies indexed under Seizures, and 19 of those are currently open to recruitment — roughly 48% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Seizures shows 6 late-stage studies (Phase 3 and Phase 4 combined) alongside 13 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Seizures is led by National Institute of Neurological Disorders and Stroke (NINDS) with 4 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 40 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Seizures?

PlainTrial tracks 40 US clinical trials for Seizures, of which 19 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Seizures?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →